Latest Weill Cornell Medical College of Cornell University Stories
NEW YORK, May 12, 2011 /PRNewswire-USNewswire/ -- Promising study results published in the May issue of JAIDS show that a novel medical device has the potential to revolutionize how male circumcision services are offered in countries hardest hit by the HIV epidemic. Conducted by EngenderHealth, a global reproductive health organization, and Weill Cornell Medical College, the study found the device, known as the Shang Ring, is highly acceptable to men and safe for further study in Africa....
JAMA study of 500,000 heart stent patients shows medical therapy from COURAGE clinical trial was applied less than half the timeA NewYork-Presbyterian Hospital/Weill Cornell Medical Center review of almost 500,000 cardiac cases nationally shows that the clinically indicated medical therapy reported in a widely publicized study was lost in translation to real-world heart care after its publication.The researchers report in the May 11 issue of JAMA, the Journal of the American Medical...
Dr. Antonio M. Gotto, a Leading Authority on Lipid Therapy and Cardiovascular Disease, and Other Physician-Scientists Are Available for Expert CommentaryAvailable for expert commentary on the latest research findings presented at the 2011 American College of Cardiology Annual Meeting in New Orleans, April 2 to 5, is Dr. Antonio M. Gotto Jr., the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College and a recognized authority on lipid therapy and cardiovascular disease.Among those...
NEW YORK, March 18, 2011 /PRNewswire/ -- Motivated by the lack of treatment options for patients with antiphospholipid syndrome (APS), rheumatology researchers convened an international committee to address the problem directly. Their creation, APS ACTION (Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking), is bringing together some of the foremost experts on APS--a little-known blood condition that can cause severe health consequences--to design clinical...
NEW YORK, Dec. 3, 2010 /PRNewswire/ -- Hospital for Special Surgery (HSS) announced the creation of the Center for Musculoskeletal Outcomes and Patient Oriented Research to translate information collected from an extensive patient population into studies that will guide experts in preventing, diagnosing and treating musculoskeletal disorders. "Through this new Center, Hospital for Special Surgery will report on the effectiveness of orthopaedic and rheumatology treatments, so physicians,...
NewYork-Presbyterian/Weill Cornell paper reports that restoring a crucial gene in a tiny area of the brain reverses depression-like behavior in mice; human data back up the promise of such therapyIn a report published in the Oct. 20 issue of Science Translational Medicine, researchers at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say animal and human data suggest gene therapy to the brain may be able to treat patients with major depression who do not respond to traditional...
WASHINGTON, Sept. 23 /PRNewswire/ -- One-year data from the PARTNER clinical trial, published yesterday in the New England Journal of Medicine, demonstrate that transcatheter aortic-valve implantation, compared with standard therapy, resulted in significantly lower rates of death among patients who cannot undergo surgery for aortic stenosis. The results will be presented today as a Late Breaking Trial at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium....
NEW YORK, Sept. 3 /PRNewswire-USNewswire/ -- For the second year in a row, Hospital for Special Surgery is the only hospital in New York State with an infection rate that is significantly lower than the state average for hip replacement or revision surgeries, according to the 2009 report on hospital infection rates released today by the State Department of Health. "At Hospital for Special Surgery, we perform more joint replacement surgery than any other hospital in the country, and...
NEW YORK, July 15 /PRNewswire/ -- Hospital for Special Surgery has been named the top hospital in the nation for orthopedics by U.S. News & World Report in its 2010 "America's Best Hospitals" issue. Once again the hospital ranked as a leader in rheumatology at number 3 in the nation. In addition, neurology was ranked at number 16. "We are deeply honored to be recognized as the leading hospital in our specialty areas in the nation," said Louis A. Shapiro, president and CEO of Hospital...
NEW YORK, July 2 /PRNewswire/ -- Hospital for Special Surgery (HSS) plans to host a two-day international Osteoarthritis Summit in June 2011. The Hospital, internationally recognized for its leadership in the fields of orthopedics and rheumatology, will bring together, for the first time, a truly comprehensive multidisciplinary group of world renowned scientists, thought-leaders and industry representatives from the United States, Canada, and Europe, to discuss all aspects of OA and develop...
